RxDoctor Payments Data

Donna Roberts, MD

Family Medicine · Bluffton, SCNPI 1255348710

Payments from drug & device makers

$240in general payments, 2019–2025

Across 16 payments — averaging $15.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$50
  • Novo Nordisk$44
  • Lilly USA, LLC$39
  • Kowa Pharmaceuticals America, Inc.$23
  • Novartis$20
  • Daiichi Sankyo Inc.$20
  • plus $44 from 3 others

What the payments were for

  • Food & beverage$240100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$240 in reported general payments places this provider in the 35th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$114,273
Medicare patients
446
Services billed
1,467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide122$153,265
TrulicityDulaglutide56$80,782
EliquisApixaban42$59,908
JardianceEmpagliflozin58$56,163
MounjaroTirzepatide35$36,639
XareltoRivaroxaban26$33,801
JanuviaSitagliptin Phosphate15$25,845
FarxigaDapagliflozin Propanediol12$17,691
ProliaDenosumab11$16,394
MyrbetriqMirabegron13$11,349
Breo ElliptaFluticasone/Vilanterol21$10,409
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$9,767
Rosuvastatin Calcium569$5,648
SynthroidLevothyroxine Sodium70$5,215
Advair DiskusFluticasone Propion/Salmeterol17$5,047

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$44$153,265122 claims
Lilly USA, LLCTrulicity, Mounjaro$39$117,42191 claims
PfizerEliquis$50$59,90842 claims
AmgenProlia$15$16,39411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Bluffton

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →